FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Hog: Eps A Penny Short Of Consensus; Prior 2026 Guidance Maintained

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Harley-Davidson (HOG) posted Q1 EPS of $0.22 vs. $1.07 (-79%), a penny short of consensus. The miss was due to weaker-than-expected margins, as motorcycle revenue fell 2% to $1.06B ($60M ahead of consensus), led by a 3% drop in motorcycle shipments. The core Harley-Davidson Motor Company (HDMC) segment, representing the company's traditional motorcycle business, experienced a dramatic 84% decline in operating income to $19M despite revenue being down only 2%. This operating leverage deterioration was led by gross margin compression of 390 bps to 25.3%. The company maintained prior 2026 guidance, which suggests no further deterioration is anticipated from the current levels. HOG shares are trading 1% higher in early trading on Tuesday. We think some investors were hopeful that HOG might be turning a corner, but it is clear the company has more challenges ahead, as it continues its long-term struggle against the global secular decline in motorcycle demand.

Related Articles

Australia

Citigroup Adjusts Price Target on Marathon Petroleum to $257 From $243, Maintains Neutral Rating

Marathon Petroleum (MPC) has an average rating of overweight and mean price target of $253.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $256.58, Change: $+4.04, Percent Change: +1.60%

$MPC
Research

Research Alert: Peg Reports Strong Q1 Beat; On Track For $4.2b Capex And 7% Eps Growth In 2026

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEG reported Q1 2026 adjusted EPS of $1.55 vs. $1.43 (+8.4% Y/Y, +8.5% vs. consensus), supported by higher PSE&G margins from regulated infrastructure investments and customer growth, partially offset by higher depreciation and interest expense. PSEG Power earnings increased due to higher realized power prices and lower O&M costs, offset by lower generation volumes. We see the company as on target for $4.2B full-year 2026 capex guidance after deploying ~$0.8B in Q1, while PEG maintained long-term targets including $24B-$28B total capex for 2026-2030 and a 6%-7.5% rate base CAGR. Management reaffirmed its 2026 EPS guidance of $4.28-$4.40, representing ~7% growth at the midpoint. Both residential electric and gas customers increased ~1% on a trailing-12-month basis, which we think reflects continued execution of the regulated investment program. Annualized dividends were increased ~6% to $2.68 for 2026. We view this as a competitive growth rate amongst Multi-Utility peers.

$PEG
Australia

Merck Completes Terns Pharmaceuticals Acquisition

Merck (MRK) said Tuesday it has completed the acquisition of Terns Pharmaceuticals after a cash tender offer at $53 per share.Terns' stock will no longer be listed on Nasdaq, it said.The deal will result in a charge to research and development expense of about $2.35 per share, included in Q2 and full year 2026 GAAP and non-GAAP results, Merck said.GAAP and non-GAAP EPS are also expected to take a hit of about $0.12 a share in 2026 on costs associated with advancing TERN-701 and costs of financing, it added.Price: $113.21, Change: $+0.10, Percent Change: +0.09%

$MRK$TERN